Nasdaq NVDA Nvidia

A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".

Wall Street's major indexes climbed on Monday on a boost from technology stocks while signs of progress in developing a COVID-19 vaccine and a spurt of multi-billion dollar deals also brightened the mood.

Nvidia Corp's $40 billion acquisition of chip designer Arm is set to catapult it into the fray of geopolitical tensions between Beijing and Washington, analysts and lawyers say.

Wall Street's major indexes climbed on Monday on a boost from technology stocks while signs of progress in developing a COVID-19 vaccine and a spurt of multi-billion dollar deals also brightened the mood.

A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".

(RTTNews) - Shares of NVIDIA Corp. (NVDA) are currently gaining nearly 8% on Monday morning after the chip maker announced its plans to buy chip design company Arm Holdings for $40 billion.

The Nasdaq Composite (NASDAQINDEX: ^IXIC) has finally faced some struggles over the past week or so, but Monday morning seemed to bring some respite for the benchmark index. Greater optimism about the potential for a COVID-19 vaccine helped to bolster sentiment among investors.

A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".

Futures pointed to a higher open for Wall Street on Monday on signs of progress in developing a COVID-19 vaccine and a flurry of multi-billion dollar deals, including reports of Oracle winning the battle for the U.S. arm of TikTok.

The NASDAQ 100 Pre-Market Indicator is up 122.74 to 11,210.14. The total Pre-Market volume is currently 26,101,176 shares traded.The following are the most active stocks for the pre-market session: Immunomedics, Inc. (IMMU) is +44.85 at $87.10, with 9,302,640 shares traded. As r

Shares of Nvidia Corp rose 6% on Monday after it announced a $40 billion deal to buy UK-based chip designer Arm from Japan's SoftBank Group Corp that, if completed, would be the chip industry's biggest ever merger.

There is a wave of major corporate announcements today, a veritable “Merger Monday” given the number of acquisitions announced this morning, including NVIDIA (NVDA) acquiring SoftBank’s ARM Holdings for $40 billion, and Oracle winning the bid for TikTok.

Nvidia Corp's $40 billion acquisition of chip designer Arm is set to catapult it into the fray of geopolitical tensions between Beijing and Washington, analysts and lawyers say.

A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".

U.S. stock index futures climbed on Monday on signs of progress in COVID-19 vaccine development and a flurry of multi-billion dollar deals, including a report of Oracle winning the battle for the U.S. arm of TikTok.

European stocks kicked off the week on a positive note as hopes of a coronavirus vaccine and a flurry of global M&A activity overshadowed worries about a disorderly Brexit.

World stocks rallied on Monday on hopes for a coronavirus vaccine after AstraZeneca resumed its phase-3 trial, but caution lingered before a host of central bank meetings this week.

HONG KONG (Reuters Breakingviews) - Nvidia has played a risky opening chess move. The U.S. listed graphics-chip specialist led by Jensen Huang will buy UK chip designer Arm from SoftBank and its Vision Fund in a deal worth up to $40 billion. But Arm's customers and regul

The head of Nvidia Corp vowed to step up investment in Britain and increase jobs there as part of its $40 billion purchase of chip designer Arm, following complaints from an Arm co-founder that the deal would destroy the company.

European stocks kicked off the week on a positive note, as hopes of a coronavirus vaccine and a flurry of global M&A activity overshadowed worries about a disorderly Brexit.